BioLife Cell Bank, Intrexon deal

BioLife and Intrexon partnered to discover and develop autologous, genetically-modified stem cell therapeutics to treat spinal muscular atrophy. Intrexon will use its technology to discover candidates. BioLife will supply stem cells and conduct preclinical and clinical development of the candidates. BioLife is also responsible for regulatory approval. Details were not disclosed. ...